BridgeMD
New treatment option for Varicose Veins
Official title The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression
ClinicalTrials.gov ID: NCT07449728
What this study is testing
- What it's testing
- Technically successful laser crossectomy will reduce the risk of reflux recurrence at the sapheno-femoral junction without increasing the risk of endovenous heat-induced thrombosis, which may positively impact the likelihood of ultrasound- or clinical-recurrence of varicose veins. Similar technical efficacy is expected for laser crossectomy at 1940 nm and 1470 nm.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \>18 years
- Primary VVs of Clinical Etiology Anatomy Pathophysiology (CEAP) clinical class of C2-C6
- Reflux along the GSV trunk lasting \>0.5 sec.
- GSV trunk diameter ≤12 mm
- Informed consent to participate in the study
You likely can't join if
- Primary reflux outside the GSV trunk (including combined reflux)
- History of deep or superficial vein thrombosis
- Deep vein reflux
- Non-thrombotic or post-thrombotic venous obstruction
- Pelvic venous insufficiency
- Use of oral anticoagulants
See the full eligibility criteria
- Age \>18 years
- Primary VVs of Clinical Etiology Anatomy Pathophysiology (CEAP) clinical class of C2-C6
- Reflux along the GSV trunk lasting \>0.5 sec.
- GSV trunk diameter ≤12 mm
- Informed consent to participate in the study
- Primary reflux outside the GSV trunk (including combined reflux)
- History of deep or superficial vein thrombosis
- Deep vein reflux
- Non-thrombotic or post-thrombotic venous obstruction
- Pelvic venous insufficiency
- Use of oral anticoagulants
- Indication for pharmacological prophylaxis after EVLT
- Inability to use radial fiber of 1.4-1.57 mm at the surgeon's discretion
- Refusal to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Moscow, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Moscow, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.